NCT04423692

Brief Summary

Covid 19 is a pandemic infection developed in late 2019

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 7, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2020

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2020

Completed
Last Updated

July 21, 2020

Status Verified

July 1, 2020

Enrollment Period

3 months

First QC Date

June 7, 2020

Last Update Submit

July 18, 2020

Conditions

Viral Infection

Outcome Measures

Primary Outcomes (1)

  • The number of pregnant women who have knowledge about covid-19

    The proper knowledge about covid-19

    one month

Study Arms (1)

pregnant women with abnormal labs

Mothers who have abnormal labs during pregnancy with abnormal coagulation profile

Other: labs

Interventions

labsOTHER

A group of questions to women regarding Corona with laboratory finding suggestive of covid 19 and coagulopathy

Also known as: Questions and counseling
pregnant women with abnormal labs

Eligibility Criteria

Age18 Years - 42 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant 6and women who have children
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Pregnant women at any GA

You may qualify if:

  • pregnant women

You may not qualify if:

  • non pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aljazeera( Al Gazeera) hospital

Giza, Egypt

RECRUITING

MeSH Terms

Conditions

Virus Diseases

Interventions

Counseling

Condition Hierarchy (Ancestors)

Infections

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Central Study Contacts

Mahmoud Alalfy

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher at national research center, egypt

Study Record Dates

First Submitted

June 7, 2020

First Posted

June 9, 2020

Study Start

June 1, 2020

Primary Completion

August 15, 2020

Study Completion

August 20, 2020

Last Updated

July 21, 2020

Record last verified: 2020-07

Locations

EG(1)